AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heindel, W.
Right arrow Articles by Roth, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heindel, W.
Right arrow Articles by Roth, B.

American Journal of Neuroradiology, Vol 14, Issue 3 629-635, Copyright © 1993 by American Society of Neuroradiology


ARTICLES

Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia

W Heindel, H Kugel and B Roth
Department of Diagnostic Radiology, University of Cologne, Koln, Federal Republic of Germany.

Using localized 1H-MR spectroscopy (1H-MRS) an inborn error of metabolism within human brain could be demonstrated, while 1H-MR imaging did not show any pathologic findings like demyelination. In two children suffering from nonketotic hyperglycinemia, the proton spectrum exhibited a large glycine signal at 3.55 ppm. In patient 1 (49-day-old girl), the pathologic signal of the inhibitory neurotransmitter glycine was of similar size in the parietooccipital white matter and in the basal ganglia region. In patient 2 (a 10-day-old girl), follow-up studies within the first 4 months of life revealed a time course of cerebral glycine content that differed from the course in plasma and cerebrospinal fluid. The continuing reduction of glycine in brain tissue corresponded more reliably with clinical findings than the stable values in plasma and cerebrospinal fluid. 1H-MRS allows the noninvasive demonstration of glycine in patients with nonketotic hyperglycinemia. This new technique may be useful to control the effect of a sodium benzoate therapy by monitoring the cerebral glycine concentration directly.


This article has been cited by other articles:


Home page
J Child NeurolHome page
A. Zenciroglu, N. Demirel, C. Aydemir, M. Ag{tau}ldere, S. Kalkanoglu, and T. Coskun
Two Cases of Glycine Encephalopathy Accompanied by Pes Equinovarus
J Child Neurol, June 1, 2005; 20(6): 533 - 535.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. Zenciroglu, N. Demirel, A. Y. Bas, C. Aydemir, M. Aggldere, S. Kalkanoglu, and T. Coskun
Two Cases of Glycine Encephalopathy Accompanied by Pes Equinovarus
J Child Neurol, June 1, 2005; 20(6): 533 - 535.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
P.-L. Khong, B. C. C. Lam, B. H. Y. Chung, K.-Y. Wong, and G.-C. Ooi
Diffusion-Weighted MR Imaging in Neonatal Nonketotic Hyperglycinemia
AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1181 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. N. Sener
Demonstration of Glycine Peaks at 3.50 ppm in a Patient with van der Knaap Syndrome
AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1587 - 1589.
[Abstract] [Full Text] [PDF]